vs
SWK Holdings Corp（SWKH）与Verastem, Inc.（VSTM）财务数据对比。点击上方公司名可切换其他公司
Verastem, Inc.的季度营收约是SWK Holdings Corp的1.3倍（$11.2M vs $8.7M）
SWK Holdings Corp是一家专注于医疗健康与生命科学领域的专业金融企业，为生物技术、制药、医疗器械及诊断类企业提供特许权使用费货币化、结构性债务、资产支持贷款等定制化融资服务，核心市场以北美地区为主。
Verastem, Inc.以Verastem Oncology品牌开展业务，是一家总部位于美国马萨诸塞州波士顿的制药企业，专注于开发抗癌治疗药物，该公司成立于波士顿，同时是纳斯达克生物技术指数成分股之一。
SWKH vs VSTM — 直观对比
营收规模更大
VSTM
是对方的1.3倍
$8.7M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.7M | $11.2M |
| 净利润 | $-19.4M | $-98.5M |
| 毛利率 | — | — |
| 营业利润率 | 9.9% | -362.2% |
| 净利率 | — | -876.3% |
| 营收同比 | -29.7% | — |
| 净利润同比 | -430.2% | -311.1% |
| 每股收益（稀释后） | $-1.59 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SWKHVSTM
| Q4 25 | $8.7M | — | ||
| Q3 25 | $10.9M | $11.2M | ||
| Q2 25 | $10.1M | $2.1M | ||
| Q1 25 | $11.8M | — | ||
| Q4 24 | $12.4M | — | ||
| Q3 24 | $10.4M | $0 | ||
| Q2 24 | $10.8M | $10.0M | ||
| Q1 24 | $11.4M | — |
净利润SWKHVSTM
| Q4 25 | $-19.4M | — | ||
| Q3 25 | $8.8M | $-98.5M | ||
| Q2 25 | $3.5M | $-25.9M | ||
| Q1 25 | $4.5M | — | ||
| Q4 24 | $5.9M | — | ||
| Q3 24 | $3.5M | $-24.0M | ||
| Q2 24 | $3.7M | $-8.3M | ||
| Q1 24 | $468.0K | — |
营业利润率SWKHVSTM
| Q4 25 | 9.9% | — | ||
| Q3 25 | 61.3% | -362.2% | ||
| Q2 25 | 46.1% | -2047.9% | ||
| Q1 25 | 68.6% | — | ||
| Q4 24 | 44.7% | — | ||
| Q3 24 | 39.2% | — | ||
| Q2 24 | 8.3% | -182.8% | ||
| Q1 24 | 9.5% | — |
净利率SWKHVSTM
| Q4 25 | — | — | ||
| Q3 25 | 80.7% | -876.3% | ||
| Q2 25 | 35.2% | -1213.6% | ||
| Q1 25 | 38.4% | — | ||
| Q4 24 | 47.5% | — | ||
| Q3 24 | 33.3% | — | ||
| Q2 24 | 33.9% | -82.6% | ||
| Q1 24 | 4.1% | — |
每股收益（稀释后）SWKHVSTM
| Q4 25 | $-1.59 | — | ||
| Q3 25 | $0.72 | $-1.35 | ||
| Q2 25 | $0.29 | $-0.62 | ||
| Q1 25 | $0.37 | — | ||
| Q4 24 | $0.47 | — | ||
| Q3 24 | $0.28 | $-0.60 | ||
| Q2 24 | $0.30 | $-0.31 | ||
| Q1 24 | $0.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.8M | $137.7M |
| 总债务越低越好 | $33.0M | — |
| 股东权益账面价值 | $235.1M | $-15.5M |
| 总资产 | $272.4M | $176.9M |
| 负债/权益比越低杠杆越低 | 0.14× | — |
8季度趋势，按日历期对齐
现金及短期投资SWKHVSTM
| Q4 25 | $42.8M | — | ||
| Q3 25 | $10.2M | $137.7M | ||
| Q2 25 | $8.0M | $164.3M | ||
| Q1 25 | $29.8M | — | ||
| Q4 24 | $5.9M | — | ||
| Q3 24 | $17.2M | $113.2M | ||
| Q2 24 | $5.5M | $83.4M | ||
| Q1 24 | $5.5M | — |
总债务SWKHVSTM
| Q4 25 | $33.0M | — | ||
| Q3 25 | $33.0M | — | ||
| Q2 25 | $33.0M | — | ||
| Q1 25 | $33.0M | — | ||
| Q4 24 | $33.0M | — | ||
| Q3 24 | $33.0M | $40.5M | ||
| Q2 24 | $33.0M | $40.3M | ||
| Q1 24 | $33.0M | — |
股东权益SWKHVSTM
| Q4 25 | $235.1M | — | ||
| Q3 25 | $254.2M | $-15.5M | ||
| Q2 25 | $246.5M | $36.1M | ||
| Q1 25 | $292.7M | — | ||
| Q4 24 | $288.7M | — | ||
| Q3 24 | $283.4M | $11.1M | ||
| Q2 24 | $282.8M | $18.9M | ||
| Q1 24 | $279.9M | — |
总资产SWKHVSTM
| Q4 25 | $272.4M | — | ||
| Q3 25 | $289.4M | $176.9M | ||
| Q2 25 | $285.7M | $196.3M | ||
| Q1 25 | $331.3M | — | ||
| Q4 24 | $332.2M | — | ||
| Q3 24 | $321.3M | $126.4M | ||
| Q2 24 | $321.0M | $105.7M | ||
| Q1 24 | $322.0M | — |
负债/权益比SWKHVSTM
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | 0.11× | — | ||
| Q3 24 | 0.12× | 3.66× | ||
| Q2 24 | 0.12× | 2.14× | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.3M | $-36.2M |
| 自由现金流经营现金流 - 资本支出 | $26.8M | — |
| 自由现金流率自由现金流/营收 | 308.1% | — |
| 资本支出强度资本支出/营收 | 5.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $43.2M | — |
8季度趋势，按日历期对齐
经营现金流SWKHVSTM
| Q4 25 | $27.3M | — | ||
| Q3 25 | $906.0K | $-36.2M | ||
| Q2 25 | $7.8M | $-32.7M | ||
| Q1 25 | $8.3M | — | ||
| Q4 24 | $23.0M | — | ||
| Q3 24 | $6.3M | $-23.8M | ||
| Q2 24 | $5.4M | $-27.6M | ||
| Q1 24 | $4.4M | — |
自由现金流SWKHVSTM
| Q4 25 | $26.8M | — | ||
| Q3 25 | $557.0K | — | ||
| Q2 25 | $7.7M | — | ||
| Q1 25 | $8.2M | — | ||
| Q4 24 | $22.9M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $5.4M | $-27.6M | ||
| Q1 24 | — | — |
自由现金流率SWKHVSTM
| Q4 25 | 308.1% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 77.0% | — | ||
| Q1 25 | 69.1% | — | ||
| Q4 24 | 185.3% | — | ||
| Q3 24 | 60.4% | — | ||
| Q2 24 | 49.7% | -275.8% | ||
| Q1 24 | — | — |
资本支出强度SWKHVSTM
| Q4 25 | 5.9% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.2% | 0.1% | ||
| Q1 24 | 0.0% | — |
现金转化率SWKHVSTM
| Q4 25 | — | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 1.82× | — | ||
| Q4 24 | 3.93× | — | ||
| Q3 24 | 1.82× | — | ||
| Q2 24 | 1.47× | — | ||
| Q1 24 | 9.47× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
VSTM
暂无分部数据
